{"filing":{"accession_number":"0001104659-26-109821","cik":"0002006986","ticker":"ADGM","company_name":"Adagio Medical Holdings, Inc.","form":"8-K","filing_date":"2026-09-23","report_date":"2026-09-23","primary_document":"adgm-20260923x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2006986/000110465926109821/adgm-20260923x8k.htm"},"events":[{"id":34486,"run_id":31733,"accession_number":"0001104659-26-109821","anchor_item_number":"2.05","event_type":"workforce_reduction","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"Adagio Medical announced a workforce reduction of 25 of 43 full-time employees (58% reduction) effective September 23, 2026, with estimated cash expenditures of approximately $1.3 million in severance, benefits, and related costs as part of a restructuring plan to extend capital resources.","company_name":"Adagio Medical Holdings, Inc.","ticker":"ADGM","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38224,"accession_number":"0001104659-26-109821","item_number":"2.05","item_title":"Costs Associated with Exit or Disposal Activities.","event_type":"workforce_reduction","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a workforce reduction of 25 of 43 full-time employees (58% reduction) effective September 23, 2026, with estimated cash expenditures of approximately $1.3 million in severance, benefits, and related costs. This is a classic Item 2.05 disclosure of exit and disposal activities associated with a restructuring plan designed to extend capital resources while the company explores strategic alternatives. The magnitude and specificity of the reduction and associated costs clearly indicate a material operational restructuring event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T12:03:37.625537+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":34487,"run_id":31733,"accession_number":"0001104659-26-109821","anchor_item_number":"8.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"summary":"The Company initiated a formal process to explore strategic alternatives, explicitly including acquisition, merger, business combination, or other transaction to maximize shareholder value. The concurrent workforce reduction and conversion price adjustment on Senior Secured Convertible Notes reflect preparation for a potential transaction.","company_name":"Adagio Medical Holdings, Inc.","ticker":"ADGM","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38225,"accession_number":"0001104659-26-109821","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The Company announced initiation of a formal process to explore strategic alternatives, which explicitly includes \"an acquisition, merger, business combination, or other transaction\" to maximize shareholder value. This is a material disclosure of M\u0026A activity in its earliest stage—the commencement of a strategic review process. The press release also notes a concurrent workforce reduction to align cost structure, and the Company lowered the conversion price on its 13% Senior Secured Convertible Notes, both consistent with preparing for a potential transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T12:03:37.625537+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38224,"accession_number":"0001104659-26-109821","item_number":"2.05","item_title":"Costs Associated with Exit or Disposal Activities.","event_type":"workforce_reduction","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a workforce reduction of 25 of 43 full-time employees (58% reduction) effective September 23, 2026, with estimated cash expenditures of approximately $1.3 million in severance, benefits, and related costs. This is a classic Item 2.05 disclosure of exit and disposal activities associated with a restructuring plan designed to extend capital resources while the company explores strategic alternatives. The magnitude and specificity of the reduction and associated costs clearly indicate a material operational restructuring event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T12:03:37.625537+00:00","company_name":"Adagio Medical Holdings, Inc.","ticker":"ADGM","filing_date":"2026-09-23"},{"id":38225,"accession_number":"0001104659-26-109821","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The Company announced initiation of a formal process to explore strategic alternatives, which explicitly includes \"an acquisition, merger, business combination, or other transaction\" to maximize shareholder value. This is a material disclosure of M\u0026A activity in its earliest stage—the commencement of a strategic review process. The press release also notes a concurrent workforce reduction to align cost structure, and the Company lowered the conversion price on its 13% Senior Secured Convertible Notes, both consistent with preparing for a potential transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T12:03:37.625537+00:00","company_name":"Adagio Medical Holdings, Inc.","ticker":"ADGM","filing_date":"2026-09-23"}]}